Survival and risk of cholangiocarcinoma in patients with primary sclerosing cholangitis: A population-based study

Scandinavian Journal of Gastroenterology

Volumn 32, Issue 10, 1997, Pages 1042-1045

  Kornfeld, D ^a   Ekbom, A ^b   Ihre, T ^b  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b NONE

Author keywords

Primary sclerosing cholangitis; Risk of cholangiocarcinoma; Survival

Indexed keywords

ARTICLE; BILE DUCT CARCINOMA; CANCER SURVIVAL; DISEASE ASSOCIATION; HUMAN; MAJOR CLINICAL STUDY; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT;

EID: 0030749011     PISSN: 00365521     EISSN: None     Source Type: Journal    
DOI: 10.3109/00365529709011222     Document Type: Article

References (21)

1. Lefkowitch JH. Primary sclerosing cholangitis. Arch Intern Med 1982;142:1157-60.
2. Lindor KD, Wiesner RH, LaRusso NF. Recent advances in managing primary sclerosing cholangitis. Semin Liver Dis 1987; 7:322-7.
3. LaRusso NF, Wiesner RH, Ludwig J, McCarthy RL. Primary sclerosing cholangitis. N Engl J Med 1984;310:899-903.
4. Chapman RWG, Marborgh BÅ, Rhodes JM, Summerfield JA, Dick R, Scheuer PJ, et al. Primary sclerosing cholangitis: a review of clinical features, cholangiography and hepatic histology. Gut 1980;21:870-7.
5. Thorpe MEC, Scheuer PJ, Sherlock S. Primary sclerosing cholangitis, the biliary tree and ulcerative colitis. Gut 1967;8: 435-48.
6. Warren KW, Athanassiades S, Monge JI. Primary sclerosing cholangitis: a study of forty-two cases. Am J Surg 1966;111:23-8.
7. Longmire WP Jr. Sclerosing cholangitis. Curr Probl Surg 1977; 14:36-43.
8. Aadland E, Schrumpf O, Fausa K, Elgjo A, Heilo T. Primary sclerosing cholangitis: a long-term follow-up study. Scand J Gastroenterol 1987;22:655-64.
9. Schrumpf E, Elgjo K, Fausa E, Gjone F, Kolmannskog F, Ritland S. Sclerosing cholangitis in ulcerative colitis. Scand J Gastroenterol 1980;15:689-97.
10. Olsson R, Danielsson A, Järnerot G, Lindström E, Lööf L, Rolny P, et al. Prevalence of primary sclerosing cholangitis in patients with ulcerative colitis. Gastroenterology 1991;100:1319-23.
11. Rosen CB, Nagorney DM, Wiesner RH, Coffey RJ, LaRusso NF. Cholangiocarcinoma complicating primary sclerosing cholangitis. Ann Surg 1991;213:21-5.
12. Broome U, Olsson R, Lööf L, Bodemar G, Hultkrantz R, Danielsson Å, et al. Natural history of prognostic factors in 305 Swedish patients with primary sclerosing cholangitis. Gut 1996; 38:610-5.
13. Wiesner RH, Grambsch PM, Dickson ER, Ludwig J, MacCarty RL, Hunter EB, et al. Primary sclerosing cholangitis: natural history, prognostic factors and survival analysis. Hepatology 1989;10:430-6.
14. Mattsson B, Wallgren A. Completeness of the Swedish Cancer Register. Nonnotified cancer recorded on death certificates in 1978. Acta Radiol Oncol 1984;23:305-13.
15. Kalbfleisch JP, Prentice RL The statistical analysis of failure time data. New York: Wiley Co.; 1980.
16. Farrant JM, Hayllar KM, Wilkinson M, Karani J, Portmann B, Westaby D, et al. Natural history and prognostic variables in primary sclerosing cholangitis. Gastroenterology 1991;100: 1710-7.
17. Dickson ER, Murtaugh PA, Wiesner RH, Grambsch PM, Fleming TR, Ludwig J, et al. Primary sclerosing cholangitis; refinement and validation of survival models. Gastroenterology 1992;103:1893-101.
18. Chapman RW, Cottone M, Selby WS, Shepherd HA, Sherlock S, Jewell DP. Serum autoantibodies, ulcerative colitis and primary sclerosing cholangitis. Gut 1986;27:89-91.
19. Cangemi JR, Russel H, Wiesner SJ, Beaver SJ, Ludwig J, MacCarty RL, et al. Effect of proctocolectomy for chronic ulcerative colitis on the natural history of primary clerosing cholangitis. Gastroenterology 1989;96:790-4.
20. O'Brien CB, Senior JR, Arora-Michandani R, Batta AK, Salen G. Urseoxycholic acid for the treatment of primary sclerosing cholangitis: a 30-month pilot study. Hepatology 1991;14:838-47.
21. Marsh JW, Iwatsuki S, Makowa L, Esquivel CO, Gordon RD, Todo S, et al. Orthotopic liver transplantation for primary sclerosing cholangitis. Ann Surg 1988;207:21-5.